| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 177,274 | 176,936 | 171,635 | 184,665 | | Cost of Revenue | 153,131 | 149,941 | 147,765 | 161,533 | | | Gross Profit | 24,143 | 26,995 | 23,870 | 23,132 | | | Operating Expenses | | Research Development |
-
| (34,077) | 34,077 |
-
| | Selling General and Administrative | (24,293) | 46,318 | (23,476) | 11,266 | | Non Recurring |
-
| (54,232) |
-
| 138,008 | | Others | 473 | 475 | 465 | 471 | | | | Total Operating Expenses |
-
| (41,516) |
-
|
-
| | | | Operating Income or Loss | 47,963 | 68,511 | 12,804 | (126,613) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 65 | 340 | 100 | 614 | | Earnings Before Interest And Taxes | 48,028 | 68,851 | 12,904 | (125,999) | | Interest Expense | 5,289 | 7,181 | 7,206 | 7,469 | | Income Before Tax | 42,739 | 61,670 | 5,698 | (133,468) | | Income Tax Expense | 3,507 | 15,210 | 1,412 | (8,484) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 39,397 | 46,460 | 4,286 | (124,984) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 39,232 | 46,460 | 4,286 | (124,984) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $39,232 | $46,460 | $4,286 | ($124,984) |
|
1.23% Nasdaq 
Income Statement
